Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Is Mr. Cooper Group Inc. (COOP) the Top Pick in Leon Cooperman’s Stock Portfolio?

We recently compiled a list titled Leon Cooperman Stock Portfolio: Top 12 Picks. In this article, we will look at where Mr. Cooper Group Inc. (NASDAQ:COOP) ranks among other stocks in Leon Cooperman’s portfolio.

Omega Advisors, Inc., an investment firm based in New York, specializes in providing advisory and portfolio management services. The firm focuses on domestic public equity and employs hedging strategies to protect its investments. Leon Cooperman, the chairman and CEO, follows a value-oriented investment strategy that emphasizes value equities and utilizes a top-down approach to select sectors for investment. His methodology integrates fundamental analysis to manage both long and short positions, which helps in constructing diversified portfolios. These portfolios are assessed against the S&P 500 index to gauge their performance effectively.

Leon G. Cooperman is a billionaire investor known for his significant contributions to the investment landscape. He is the first in his family to earn a college degree, graduating from Hunter College, where he was active in the Alpha Epsilon Pi fraternity. After completing his education, Cooperman began his career as a quality control engineer at Xerox in 1965 and later earned an MBA from Columbia Business School in 1967. He is also a Chartered Financial Analyst (CFA), which reflects his deep knowledge of investment analysis and portfolio management.

Leon Cooperman Warns of Rising National Debt

In a recent CNBC interview on September 25, Leon Cooperman expressed significant concerns about two main issues affecting the economy. He highlighted the national debt, which has surged from $20 trillion in 2017 to $34 trillion in 2024, growing at a rate that far outpaces the economy. He warns that this increase could lead to serious problems in the future, especially since candidates running for office are not addressing the deficit.

“I’m very concerned about two things. One is the debt buildup. We have two candidates running for office, and neither one talks about the deficit or the buildup of debt. In 2017, I think our national debt was $20 trillion. Seven years later, it’s $34 trillion. That’s a growth rate far in excess of the growth rate of the economy, and it’s going to be a problem one day.”

When asked if the Fed’s rate cuts have led him to invest more in stocks, Leon Cooperman replied that he is already fully invested, primarily in various assets. He has allocated about 20% of his portfolio to bonds and believes the government’s conduct is disappointing. Additionally, he has around 15% in energy investments, seeing potential in that sector due to current events in the Middle East. He noted that while the Fed is cutting short-term rates, he anticipates long-term rates will rise, particularly for ten-year bonds.

Cooperman was also asked about the Fed’s rate cuts and their impact on the economy. He responded that short-term rates are currently too high compared to historical standards. He explained that the yield on the ten-year government bond should align with GDP growth, which he estimates at around 5% (2.5% real growth plus 2.5% inflation). He believes that at a 5% yield, the ten-year bond is undervalued and anticipates rates will rise.

Leon Cooperman Thinks “Stocks Are The Place To Be”

Leon Cooperman expressed concerns about the potential future problems with government debt, suggesting that issues may arise unexpectedly. At 81 years old, he reflected on his experience during past market bubbles in 2000 and 1972, emphasizing his belief that stocks remain the best investment choice while avoiding bonds.

“I may be too old. Take me out behind the barn and shoot me. I’m 81 years old. I’ve been through a couple of bubbles—the 2000 bubble and the 1972 bubble… I think stocks are the best place to be. I would avoid bonds.”

Our Methodology

This article reviews the top 12 stock holdings of Omega Advisors as of the second quarter of 2024, highlighting the number of hedge funds also invested in these companies. The stocks are organized in ascending order based on Omega Advisors’ stake as of June 30, 2024.

At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

Mr. Cooper Group Inc. (NASDAQ:COOP)

Total Number of Shares Owned: 2,860,600

Total Value of Shares Owned: $232,366,538

Number of Hedge Fund Investors: 37

In Q2 2024, Mr. Cooper Group Inc. (NASDAQ:COOP) reported impressive earnings, with earnings per share (EPS) of $2.52, surpassing analyst expectations of $2.33. Mr. Cooper Group Inc. (NASDAQ:COOP) also achieved a revenue of $583 million, reflecting a 3.4% increase from the previous year. Notably, Mr. Cooper Group Inc. (NASDAQ:COOP) pretax operating income soared by 46% year-over-year to $219 million, highlighting significant operational efficiency and profitability.

A key factor in this positive outlook is the strategic acquisition of Flagstar’s mortgage operations for $1.4 billion in cash. This acquisition brought in $1.2 billion in mortgage servicing rights and expanded Mr. Cooper Group Inc. (NASDAQ:COOP)’s servicing portfolio to a total of $1.2 trillion, significantly bolstering its servicing business. With a growing subservicing mix making up 52% of the portfolio, this move strengthens Mr. Cooper Group Inc. (NASDAQ:COOP)’s position in the market.

Additionally, Mr. Cooper Group Inc. (NASDAQ:COOP)’s tangible book value per share increased by 17% year-over-year to $68.67, demonstrating solid financial health.Mr. Cooper Group Inc. (NASDAQ:COOP) has also been proactive in returning value to shareholders, reducing outstanding shares by 4% over the past year through its share repurchase program and allocating an additional $200 million for future buybacks.

Moreover, Mr. Cooper Group Inc. (NASDAQ:COOP)’s servicing revenue grew by 37% year-over-year, supported by a record low delinquency rate of just 1%. This combination of efficiency and a robust servicing portfolio positions Mr. Cooper Group Inc. (NASDAQ:COOP) well to capitalize on growth opportunities in the mortgage servicing sector.

Omega Advisors, Inc. has 2,860,600 shares of Mr. Cooper Group Inc. (NASDAQ:COOP), valued at $232,366,538.

Diamond Hill Select Strategy stated the following regarding Mr. Cooper Group Inc. (NASDAQ:COOP) in its Q2 2024 investor letter:

“Among our top individual contributors in Q2 were Amazon, Texas Instruments and Mr. Cooper Group Inc. (NASDAQ:COOP). Mortgage-servicing company Mr. Cooper Group is benefiting from a high interest-rate environment, which is supporting increased profitability in the mortgage-servicing business.”

Overall COOP ranks 1st on our list of top picks in Leon Cooperman’s stock portfolio. While we acknowledge the potential of COOP as an investment, our conviction lies in the belief that under the radar AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than COOP but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.

Disclosure: None. This article is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by 15% and offering month-to-month subscriptions with no commitments.

For a ridiculously low price of just $6.99 per month, you can unlock our in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on our Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• One New Issue of Our Premium Readership Newsletter: You will also receive one new issue per month and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a month of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• Lifetime Price Guarantee: Your renewal rate will always remain the same as long as your subscription is active.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $6.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!

NYSE-traded tiny biotech firm has a revolutionary offering to the medical world since antibiotics!

Tiny NYSE-traded biotech firm is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

The Company’s virus-specific nanoviricides have been created against important viruses such as HIV, Influenza and Bird Flu by choosing highly virus-specific ligands.

Broad-spectrum nanoviricides have been created that can bind to possibly as many as 90-95% of known viruses. The Company is also developing broad-spectrum nanoviricides to combat several neglected tropical diseases, such as Dengue, Rabies, and Ebola/Marburg.

Its one lead drug alone potentially addresses a $2.5 to $4.3 Billion market.

Click to continue reading…